Brokerages Set Surgery Partners, Inc. (NASDAQ:SGRY) Price Target at $32.00

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have received a consensus rating of “Moderate Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $32.00.

Several equities research analysts have weighed in on the company. Bank of America began coverage on Surgery Partners in a report on Monday, July 28th. They issued a “buy” rating and a $28.00 price target for the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $36.00 target price on shares of Surgery Partners in a research note on Tuesday, October 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Surgery Partners in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. began coverage on shares of Surgery Partners in a research note on Thursday, September 18th. They set a “neutral” rating and a $27.00 price target on the stock.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa Deluca sold 20,018 shares of the stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total value of $455,209.32. Following the transaction, the director directly owned 45,173 shares of the company’s stock, valued at approximately $1,027,234.02. This represents a 30.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Harrison R. Bane sold 9,339 shares of Surgery Partners stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $22.48, for a total value of $209,940.72. Following the sale, the insider directly owned 117,181 shares of the company’s stock, valued at $2,634,228.88. This trade represents a 7.38% decrease in their position. The disclosure for this sale can be found here. 2.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Surgery Partners

Institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC lifted its stake in Surgery Partners by 7,902.7% during the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company’s stock valued at $211,000 after acquiring an additional 8,772 shares during the period. CIBRA Capital Ltd acquired a new stake in shares of Surgery Partners in the first quarter worth $1,357,000. Teacher Retirement System of Texas purchased a new position in shares of Surgery Partners during the first quarter worth $447,000. Principal Financial Group Inc. lifted its position in Surgery Partners by 9.5% during the first quarter. Principal Financial Group Inc. now owns 54,266 shares of the company’s stock valued at $1,289,000 after purchasing an additional 4,717 shares during the period. Finally, Bank of New York Mellon Corp boosted its holdings in Surgery Partners by 0.3% in the first quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company’s stock valued at $8,115,000 after purchasing an additional 926 shares during the last quarter.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $19.74 on Friday. The business’s fifty day simple moving average is $22.13 and its 200-day simple moving average is $22.16. The company has a market cap of $2.53 billion, a PE ratio of -13.80 and a beta of 1.83. The company has a current ratio of 1.93, a quick ratio of 1.78 and a debt-to-equity ratio of 1.10. Surgery Partners has a 12-month low of $18.87 and a 12-month high of $33.37.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The firm had revenue of $826.20 million during the quarter, compared to analysts’ expectations of $816.96 million. During the same quarter last year, the firm earned $0.21 EPS. The business’s quarterly revenue was up 8.4% on a year-over-year basis. Analysts expect that Surgery Partners will post 0.67 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.